Cardioverter Defibrillator Devices Market

Increasing prevalence of cardiovascular disease, sudden cardiac arrest (SCA), and related death remains a significant public health issue across the globe. Variety of non-pharmacologic therapies for primary and secondary prevention of SCA and their management including implantable and wearable defibrillators are available in the market. Cardioverter defibrillators have become a significant therapeutic modality among all for patients who have had a cardiac arrest or are at risk for life-threatening ventricular arrhythmias.

Cardioverter Defibrillator Devices Market contains market size and forecasts of Cardioverter Defibrillator Devices in global, including the following market information:

• Global Cardioverter Defibrillator Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Cardioverter Defibrillator Devices Market Sales, 2017-2022, 2023-2028, (Units)
• Global top five Cardioverter Defibrillator Devices companies in 2021 (%)

The global Cardioverter Defibrillator Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Implantable Cardioverter Defibrillator Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cardioverter Defibrillator Devices include Fukuda Denshi(Japan), LivaNova(U.K.), Medtronic(Ireland), Progetti(Italy), Schiller(Switzerland), Abbott Laboratories(U.S.), BIOTRONIK(Germany), Boston Scientific Corporation(U.S.) and Cardiac Science corporation(U.S.), etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cardioverter Defibrillator Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cardioverter Defibrillator Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Cardioverter Defibrillator Devices Market Segment Percentages, by Type, 2021 (%)

• Implantable Cardioverter Defibrillator
• External Cardioverter Defibrillator

Global Cardioverter Defibrillator Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Cardioverter Defibrillator Devices Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Ambulatory Surgery Centers
• Others

Global Cardioverter Defibrillator Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Cardioverter Defibrillator Devices Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Cardioverter Defibrillator Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Cardioverter Defibrillator Devices revenues share in global market, 2021 (%)
• Key companies Cardioverter Defibrillator Devices sales in global market, 2017-2022 (Estimated), (Units)
• Key companies Cardioverter Defibrillator Devices sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Fukuda Denshi(Japan)
• LivaNova(U.K.)
• Medtronic(Ireland)
• Progetti(Italy)
• Schiller(Switzerland)
• Abbott Laboratories(U.S.)
• BIOTRONIK(Germany)
• Boston Scientific Corporation(U.S.)
• Cardiac Science corporation(U.S.)
• Koninklijke Philips(Netherlands)
• Nihon Kohden Corporation(Japan)
• Stryker Corporation(U.S.)
• Zoll medical corporation(U.S.)